discontinued

bs-8547R Minor capsid protein L2 antibody

See related secondary antibodies

Search for all "Minor capsid protein L2"

0.1 ml / €240.00

Quick Overview

Rabbit anti Virus Minor capsid protein L2

bs-8547R

Product Description for Minor capsid protein L2

Rabbit anti Virus Minor capsid protein L2.
Presentation: Purified
Product is tested for Paraffin Sections.

Properties for Minor capsid protein L2

Product Category Primary Antibodies
Quantity 0.1 ml
Presentation Purified
Reactivity Vi
Applications P
Clonality Polyclonal
Host Rabbit
Isotype IgG
Shipping to Europe only
PDF datasheet View Datasheet
Manufacturer Bioss, Inc.

Datasheet Extract

Immunogen
Swiss Prot Num:
P03107
Immunogen:
KLH conjugated synthetic peptide derived from HPV16 L2.
GeneID:
1489081
Application IHC-P(1:100-500)
IF(IHC-P)(1:50-200)
Background Human papillomaviruses, particularly type 16 (designated HPV16), infect the genital tract and may lead to cervical cancer. Protection against HPV16 is thought to be provided by neutralizing directed to the major caspid protein L1 of HPV16. HPV16 L1 forms the pentameric assembly unit of the viral shell, and the binding of HPV16 L1 to the cell surface without the involvement of minor capsid protein L2 is believed to be the first step of HPV16 infection. The L1-binding domain located near the C-terminus of L2 binds L1 prior to completion of capsid assembly and is required for efficient encapsidation of the viral genome. In addition, the C-terminus of L1 is necessary for both DNA binding and DNA packaging. Expression of the late gene L1 is restricted to the upper layers of the infected epithelium. HPV16 L1 is able to package unrelated plasmid DNA in vitro and deliver the foreign DNA to eukaryotic cells with the subsequent expression of the encoded gene. L1 shows a diffuse nuclear distribution whereas L2 is localized to punctate nuclear regions identified as promonocytic leukemia protein oncogenic domains (PODs). Coexpression of L1 and L2 induces a relocalization of L1 into the PODs.
Storage Store at -20°C for 12 months.
Format
Purification:
Purified by Protein A.
Buffer System:
Aqueous buffered solution containing 100ug/ml BSA, 50% glycerol and 0.09% sodium azide.
State:
Purified

Accessory Products

  • LinkedIn